Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress

R Magierski, T Sobow, E Schwertner… - Frontiers in …, 2020 - frontiersin.org
The core symptoms of different dementia subtypes are the behavioral and psychological
symptoms of dementia (BPSD) and its neuropsychiatric symptoms (NPS). BPSD symptoms …

The neuropsychiatric inventory: development and applications

J Cummings - Journal of geriatric psychiatry and neurology, 2020 - journals.sagepub.com
Reasons for the Study: The Neuropsychiatric Inventory (NPI) has been used for studies of
neuropsychiatric symptoms in neurodegenerative disorders for the past 25 years. This article …

Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition

M Sano, J Cummings, S Auer, S Bergh… - International …, 2024 - cambridge.org
Background: The International Psychogeriatric Association (IPA) published a provisional
consensus definition of agitation in cognitive disorders in 2015. As proposed by the original …

Behavioral and psychiatric symptoms of dementia and rate of decline in Alzheimer's disease

RT Gottesman, Y Stern - Frontiers in pharmacology, 2019 - frontiersin.org
Alzheimer's disease causes both cognitive and non-cognitive symptoms. There is increasing
evidence that the presentation and course of Alzheimer's disease is highly heterogenous …

Exploring the relationship between patient-relevant outcomes and Alzheimer's disease progression assessed using the clinical dementia rating scale: a systematic …

J Cummings, JH Hahn-Pedersen, CS Eichinger… - Frontiers in …, 2023 - frontiersin.org
Background People with Alzheimer's disease (AD) have difficulties in performing activities of
daily living (ADLs) as the disease progresses, commonly experience neuropsychiatric …

Agitation in dementia: real-world impact and burden on patients and the healthcare system

E Jones, MS Aigbogun, J Pike, M Berry… - Journal of …, 2021 - content.iospress.com
Background: At least 90% of patients with dementia experience behavioral or
neuropsychiatric symptoms including agitation, psychotic symptoms, apathy, depression …

Content development and validation for a mobile application designed to train family caregivers in the use of music to support care of people living with dementia

Z Thompson, J Tamplin, T Vieira Sousa… - Frontiers in …, 2023 - frontiersin.org
Background Music therapy is increasingly recognized as an effective support for people
living with dementia. However, with incidences of dementia increasing, and limited …

Effects of the 2018 Japan Floods on long-term care insurance costs in Japan: retrospective cohort study

S Yoshida, S Kashima, S Ishii, S Koike, M Matsumoto - BMC Public Health, 2022 - Springer
Background Climate change has increased the frequency and severity of torrential rains and
floods around the world. Estimating the costs of these disasters is one of the five global …

Pharmacotherapeutic combinations for the treatment of Alzheimer's disease

T Nagata, S Shinagawa, S Nakajima… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Alzheimer's disease (AD) is the most common form of dementia, and four
medications are currently available as symptomatic therapies: three cholinesterase …

Pathogenesis and personalized interventions for pharmacological treatment-resistant neuropsychiatric symptoms in Alzheimer's disease

T Nagata, S Shinagawa, K Inamura… - Journal of Personalized …, 2022 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia, with cognitive impairment
as a core symptom. Neuropsychiatric symptoms (NPSs) also occur as non-cognitive …